Molecular basis for effects of carcinogenic heavy metals on inducible gene expression

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 4, 1998, Pages 1005-1015

  Hamilton, Joshua W ^a   Kaltreider, Ronald C ^b   Bajenova, Olga V ^b   Ihnat, Michael A ^b   McCaffrey, Jennifer ^b   Turpie, Bruce W ^b   Rowell, Erin E ^b   Oh, Jannet ^b   Nemeth, Michael J ^b   Pesce, Carrie A ^b   Lariviere, Jean P ^b  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Arsenic; Chromium; Genetic constructs; Mitomycin C; Phosphoenolpyruvate carboxykinase; Transcription factors; Transfection

Indexed keywords

ARSENIC; CELL PROTEIN; CHROMIUM; DNA; HEAVY METAL; LUCIFERASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); THIOL DERIVATIVE; TRANSCRIPTION FACTOR;

ANIMAL CELL; CARCINOGENESIS; CELL CULTURE; CHICK EMBRYO; CHROMATIN; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HEPATOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RAT; REPORTER GENE;

EID: 17344383272     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s41005     Document Type: Conference Paper

References (70)

1. Hamilton JW, Wetterhahn KE. Chromium. In:Handbook on Toxicity of Inorganic Compounds (Seiler HG, Sigel H, eds). New York:Marcel Dekker, 1987;239-250.
2. Fan AM, Harding-Barlow I. Chromium. In:Genotoxic and Carcinogenic Metals:Environmental and Occupational Occurrence and Exposure (Fishbein L, Furst A, Mehlman MA, eds). Princeton, NJ:Princeton Scientific Publishing, 1987;87-126.
3. Bencko V. Arsenic. In:Genotoxic and Carcinogenic Metals:Environmental and Occupational Occurrence and Exposure (Fishbein L, Furst A, Mehlman MA, eds). Princeton NJ:Princeton Scientific Publishing, 1987;1-30.
4. De Flora S, Wetterhahn KE. Mechanisms of chromium metabolism and genotoxicity. Life Chem Rep 7:169-244 (1989).
5. Langard S. The carcinogenicity of chromium compounds in man and animals. In:Chromium:Metabolism and Toxicity (Burrows D, ed). Boca Raton, FL:CRC Press, 1983;13-30.
6. Landolph JR. Neoplastic transformation of mammalian cells by carcinogenic metal compounds:cellular and molecular mechanisms. In:Biological Effects of Heavy Metals. Vol II:Metal Carcinogenesis (Foulkes EC, ed). Boca Raton, FL:CRC Press, 1990;1-18.
7. IARC. Arsenic and Arsenic Compounds (Group 1). In:IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans, Vol 7. Lyon:International Agency for Research on Cancer, 1987;100-106.
8. Wetterhahn KE, Hamilton JW, Aiyar J, Borges KM, Floyd R. Mechanism of chromium (VI) carcinogenesis:reactive intermediates and effect on gene expression. Biol Trace Elem Res 21:405-411 (1989).
9. Wetterhahn KE, Hamilton JW. Molecular basis of hexavalent chromium carcinogenicity:effect on gene expression. Sci Total Environ 86:113-129 (1989).
10. Hamilton JW, Wetterhahn KE. Differential effects of chromium(VI) on constitutive and inducible gene expression in chick embryo liver in vivo and correlation with chromium(VI)-induced DNA damage. Mol Carcinogen 2:274-286 (1989).
11. Hamilton JW, McCaffrey J, Caron RM, Louis CA, Treadwell MD, Hunt SR, Reed MJ, Doherty KA. Genotoxic chemical carcinogens target inducible genes in vivo. Ann NY Acad Sci 726:343-345 (1994).
12. McCaffrey J, Wolf CM, Hamilton JW. Effects of the genotoxic carcinogen chromium(VI) on basal and hormone-inducible phosphoenolpyruvate carboxykinase gene expression in vivo:correlation with glucocorticoid- and developmentally-regulated expression. Mol Carcinogen 10:189-198 (1994).
13. Hamilton JW, Louis CA, Doherty KA, Hunt SR, Reed MJ, Freadwell MD. Preferential alteration of inducible gene expression in vivo by carcinogens that induce bulky DNA lesions. Mol Carcinogen 8:34-43 (1993).
14. Hamilton JW, Wetterhahn KE. Chromium(VI)-induced DNA damage in chick embryo liver and blood cells in vivo. Carcinogenesis 7:2085-2088 (1986).
15. Chang WC, Chen SH, Wu HL, Shi GY, Murota S, Morita I. Cytoprotective effect of reduced glutathione in arsenical-induced endothelial cell injury. Toxicology 69:101-110 (1991).
16. Sanchez ER. Heat shock induces translocation to the nucleus of the unliganded glucocorticoid receptor. J Biol Chem 267:17-20 (1992).
17. Lopez S, Miyashita Y, Simons SS Jr. Structurally based, selective interaction of arsenite with steroid receptors. J Biol Chem 265:16039-16042 (1990).
18. Thompson DJ. A chemical hypothesis for arsenic methylation in mammals. Chem Biol Interact 88:89-114 (1993).
19. Yanez L, Carrizales L, Zanatta MT, Mejia JJ, Batres L, Diaz-Barriga F. Arsenic-cadmium interaction in rats:toxic effects in the heart and tissue metal shifts. Toxicology 67:227-234 (1991).
20. Hamilton JW, Bement WJ, Sinclair PR, Sinclair JF, Wetterhahn KE. Expression of 5-aminolaevulinate synthase and cytochrome P-450 mRNAs in chicken embryo hepatocytes in vivo and in cell culture:effect of porphyrinogenic drugs and haem. Biochem J 255:267-275 (1988).
21. Hamilton JW, Denison MS, Bloom SK. Development of basal and induced aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity in the chicken embryo in ovo. Proc Natl Acad Sci USA 80:3372-3376 (1983).
22. Ihnat MA, Lariviere JP, Warren AJ, La Ronde N, Blaxall JRN, Pierre KM, Turpie BW, Hamilton JW. Suppression of P-glycoprotein expression and multidrug resistance by DNA crosslinking agents. Clin Cancer Res 3:1339-1346 (1997).
23. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acid Res 11:1475-1489 (1983).
24. Janssen YM, Barchowsky A, Treadwell MD, Driscoll KE, Mossman BT. Asbestos induces nuclear factor kappa B (NF-κB) DMA-binding activity and NF-κB dependent gene expression in tracheal epithelial cells. Proc Natl Acad Sci USA 92:8458-8462 (1995).
25. Hamilton JW, Bement WJ, Sinclair PR, Sinclair JF, Alcedo JA, Wetterhahn KE. Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. Arch Biochem Biophys 289:387-392 (1991).
26. Hamilton JW, Bement WJ, Sinclair PR, Sinclair JF, Alcedo JA, Wetterhahn KE. Inhibition of protein synthesis increases the transcription of the phenobarbital-inducible CYP2H1 and CYP2H2 genes in chick embryo hepatocytes. Arch Biochem Biophys 298:96-104 (1992).
27. Curran T, Gordon MB, Rubino KL, Sambucetti LC. Isolation and characterization of the c-fos (rat) cDNA and analysis of posttranslational modification in vitro. Oncogene 2:79-84 (1987).
28. Lamph WW, Wamsley P, Sassone-Corsi P, Verma IM. Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature 334:629-631 (1988).
29. Papathanasiou MA, Kerr NC, Robbins JH, McBride OW, Alamo I Jr, Barrett SF, Hickson ID, Fornace AJ Jr. Induction by ionizing radiation of the gadd45 gene in cultured human cells:lack of mediation by protein kinase C. Mol Cell Biol 11:1009-1016 (1991).
30. Park JS, Luethy JD, Wang MG, Fargnoli J, Fornace AJ Jr, McBride OW, Holbrook NJ. Isolation, characterization and chromosomal localization of the human GADD153 gene. Gene 116:259-267 (1992).
31. Beale EG, Chrapkiewicz NB, Scoble HA, Metz RJ, Quick DP, Noble RL, Donelson JE, Biemann K, Granner DK. Rat hepatic cytosolic phosphoenolpyruvate carboxykinase (GTP):structures of the protein, messenger RNA, and gene. J Biol Chem 260:10748-10760 (1985).
32. Chodosh LA. Mobility shift DNA-binding assay using gel electrophoresis. In:Current Protocols in Molecular Biology (Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds). New York:John Wiley & Sons, 1993;12.2.1-12.2.10.
33. Read MA, Whitley MZ, Williams AJ, Collins T. NF-κB and I-κB alpha:an inducible regulatory system in endothelial activation. J Exp Med 179:503-512 (1994).
34. McCaffrey J, Hamilton JW. Comparison of effects of direct-acting DNA methylating and ethylating agents on inducible gene expression in vivo. Environ Mol Mutagen 23:164-170 (1994).
35. Caron RM, Hamilton JW. Preferential effects of the chemotherapeutic DNA crosslinking agent mitomycin C on inducible gene expression in vivo. Environ Mol Mutagen 25:4-11 (1995).
36. Alcedo JA, Misra M, Hamilton JW, Wetterhahn KE. The genotoxic carcinogen chromium(VI) alters the metal-inducible expression but not the basal expression of the metallothionein gene in vivo. Carcinogenesis 15:1089-1092 (1994).
37. 1-induced unscheduled DNA synthesis in the chick embryo, in vivo. Environ Mutagen 6:41-48 (1984).
38. Hamilton JW, Bloom SE. Correlation between induction of xenobiotic metabolism and DNA damage from chemical carcinogens in the chick embryo in vivo. Carcinogenesis 7:1101-1106 (1986).
39. Bloom SE. Avian and aquatic systems for in vivo detection of sister chromatid exchange. In:Sister Chromatid Exchange (Sandberg AA, ed). New York:Alan R. Liss, 1982;249-277.
40. Hamilton JW, Bloom SE. Developmental differences in basal and induced aryl hydrocarbon (benzo[a]pyrene) hydroxylase activity in chick embryo liver and lung in vivo. Biochem Pharmacol 32:2986-2988 (1983).
41. Denison MS, Okey AB, Hamilton JW, Bloom SE, Wilkinson CF. Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin:ontogeny in chick embryo liver. J Biochem Toxicol 1:39-49 (1986).
42. Hamilton JW, Caron RM, Ihnat MA, Warren AJ, Kaltreider RC. Unpublished observations.
43. Granner D, O'Brien R, Imai E, Forest C, Mitchell J, Lucas P. Complex hormone response unit regulating transcription of the phosphoenolpyruvate carboxykinase gene:from metabolic pathways to molecular biology. Rec Prog Horm Res 47:319-346 (1991).
44. Lucas PC, Granner DK. Hormone response domains in gene transcription. Annu Rev Biochem 61:1131-1173 (1992).
45. Cornwell MM, Smith DE. SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J Biol Chem 268:19505-19511 (1993).
46. Madden MJ, Morrow CS, Nakagawa M, Goldsmith ME, Fairchild CR, Cowan KH. Identification of 5′and 3′ sequences involved in the regulation of transcription of the human mdr1 gene in vivo. J Biol Chem 268:8290-8297 (1993).
47. Chin K-V, Pastan I, Gottesman MM. Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60:157-180 (1993).
48. Cohen D, Piekarz RL, Hsu SI, DePinho RA, Carrasco N, Horwitz SB. Structural and functional analysis of the mouse mdr1b gene promoter. J Biol Chem 266:2239-2244 (1991).
49. Hanson RW, Patel YM. Phosphoenolpyruvate carboxykinase (GTP):the gene and the enzyme. Adv Enzymol Rel Areas Mol Biol 69:203-281 (1994).
50. Sachsenmaier C, Radler-Pohl A, Muller A, Herrlich P, Rahmsdorf HJ. Damage to DNA by UV light and activation of transcription factors. Biochem Pharmacol 47:129-136 (1994).
51. Herrlich P, Sachsenmaier C, Radler-Pohl A, Gebel S, Blattner C, Rahmsdorf HJ. The mammalian UV response:mechanism of DNA damage induced gene expression. Adv Enzyme Reg 34:381-395 (1994).
52. Fornace AJ, Jr., Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 9:4196-4203 (1989).
53. Hollander MC, Fornace AJ Jr. Induction of fos RNA by DNA-damaging agents. Cancer Res 49:1687-1692 (1989).
54. Devary Y, Gottlieb R, Lau LF, Karin M. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol Cell Biol 11:2804-2811 (1991).
55. 1 of hydrocortisone induction of rat liver tryptophan pytrolase and tyrosine transaminase. Arch Biochem Biophys 128:509-516 (1968).
56. Miller MS, Wogan GN. Inhibition of steroid-inducible tyrosine aminotransferase gene expression by N-methyl-N'-nitro-N-nitrosoguanidine in a rat hepatoma cell line. Carcinogenesis 7:1273-1278 (1986).
57. Gayda DP, Pariza MW. Effects of carcinogens on hormonal regulation of gene expression in primary cultures of adult rat hepatocytes. Carcinogenesis 4:1127-1131 (1983).
58. Yeoh GCT, Toia RF, Godfrey ML, Adler B. The development of mixed function amine oxidase in cultured foetal rat hepatocytes and its relation to 3′-methyl-4-N,N-dimethylamino- azobenzene effects on tyrosine aminotransferase accumulation. Carcinogenesis 4:1499-1501 (1983).
59. Huang D-P, Maine AB, Chiu J-F. Changes in hepatic levels of tyrosine aminotransferase messenger RNA during chemical carcinogenesis. Cancer Lett 22:143-149 (1984).
60. McCaffrey J, Hamilton JW. Developmental regulation of basal and hormone-inducible phoshpenolpyruvate carboxykinase gene expression in chick embryo liver in vivo. Arch Biochem Biophys 309:10-17 (1994).
61. Caron RM, Hamilton JW. Developmentally specific effects of the DNA crosslinking agent mitomycin C on phosphoenolpyruvate carboxykinase gene expression in vivo:correlation with changes in chromatin structure within the promoter region of the gene. J Biochem Mol Toxicol (in press).
62. Fornace AJ Jr, Alamo I Jr, Hollander MC. DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85:8800-8804 (1988).
63. Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW, Fornace AJ Jr. Analysis of the mammalian gadd45 gene and its response 10 DNA damage. J Biol Chem 88:3729-3733 (1993).
64. DeLuca LM. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB 5:2924-2933 (1991).
65. Yu L, Cohen D, Piekarz RL, Horwitz SB. Three distinct nuclear binding sites in the promoter of the marine mdr1b gene. J Biol Chem 268:7520-7526 (1993).
66. Luethy JD, Holbrook NJ. Activation of the gadd153 promoter by genotoxic agents:a rapid and specific response to DNA damage. Cancer Res 52:5-10 (1992).
67. Jackman J, Alamo I Jr, Fornace AJ Jr. Genotoxic stress confers preferential und coordinate messenger RNA stability on the five gadd genes. Cancer Res 54:5656-5662 (1994).
68. Farmer PB, Bailey E, Campbell JB. Use of alkylated Proteins in the monitoring of exposure to alkylating agents. IARC Sci Publ 59:189-198 (1984).
69. Kuo ML, Meng TC, Lin JK. Involvement of glutathione in induction of c-jun proto-oncogene by methyl methanesulfonate in NIH 3T3 cells. Carcinogenesis 17:815-820 (1996).
70. Carrier F. Gatignol A, Hollander MC, Jeang KT, Fornance AJ Jr. Induction of RNA-binding proteins in mammalian celIs by DNA-damaging agents. Proc Natl Acad Sci USA 91:1554-1558 (1994).